Acerca de Lat0k

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam viverra euismod odio, gravida pellentesque urna varius vitae. Sed dui lorem, adipiscing in adipiscing et, interdum nec metus. Mauris ultricies, justo eu convallis placerat, felis enim ornare nisi vitae.
This Is A Custom Message You Can Customize In Your Admin!

An Active Substance Master File…

An Active Substance Master File (ASMF) can be used to replace the documentation for an active substance, required as part of an initial marketing authorisation application (MAA) or subsequent marketing authorisation variation (MAV). Appropriate guidance is given in the CHMP/CVMP guideline on active substance master file procedure. A specific ASMF can be used for multiple [...]

Por |2023-08-28T20:04:23+00:00agosto 28th, 2023|Noticias|Sin comentarios

Updated annexes to the eSubmission roadmap published

The following updated Annexes to the eSubmission Roadmap have been published to reflect further details on the practical implementation steps. Annex 3 to the HMA eSubmission Roadmap on the implementation of mandatory VNeeS format for Veterinary regulatory submissions, Annex 4 to the HMA eSubmission Roadmap on the replacement of the current PDF electronic application forms [...]

Por |2023-08-17T02:48:01+00:00agosto 17th, 2023|Noticias|Sin comentarios

updated Annexes to the Roadmap

The updated Annexes to the Roadmap are being published as they become available to reflect further details on the practical implementation steps. Annex 1 to the HMA eSubmission Roadmap on the implementation of eCTD version 4.0 and Annex 2 to the HMA eSubmission Roadmap on the implementation of mandatory use of eCTD format for Human [...]

Por |2023-08-16T02:36:26+00:00agosto 16th, 2023|Noticias|Sin comentarios

Common Repository (User Interface and API) is now extended to include the following types of submissions related to procedures for Human Medicinal Products: Signal Detection, PASS 107 NAPs, Work share NAPs and Ancillary products for new submissions from the 8th of March 2018 onwards.

Common Repository (User Interface and API) is now extended to include the following types of submissions related to procedures for Human Medicinal Products: Signal Detection, PASS 107 NAPs, Work share NAPs and Ancillary products for new submissions from the 8th of March 2018 onwards. This will be followed by a transitional period of 6-9 months, [...]

Por |2023-08-11T02:17:33+00:00agosto 11th, 2023|Noticias|Sin comentarios
Ir a Arriba